Dr. Kushal Naha
Claim this profileUniversity of Missouri - Ellis Fischel
Studies Cancer
Studies Bladder Cancer
13 reported clinical trials
38 drugs studied
Area of expertise
1Cancer
Stage IV
Stage II
Stage I
2Bladder Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Kushal Naha is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Kushal Naha
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Kushal Naha has experience with
- Gemcitabine Hydrochloride
- Nivolumab
- Atezolizumab
- Docetaxel
- Ipilimumab
- Cabozantinib
Breakdown of trials Kushal Naha has run
Cancer
Bladder Cancer
Transitional Cell Carcinoma
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kushal Naha specialize in?
Kushal Naha focuses on Cancer and Bladder Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is Kushal Naha currently recruiting for clinical trials?
Yes, Kushal Naha is currently recruiting for 7 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Kushal Naha has studied deeply?
Yes, Kushal Naha has studied treatments such as Gemcitabine Hydrochloride, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Kushal Naha?
Apply for one of the trials that Kushal Naha is conducting.
What is the office address of Kushal Naha?
The office of Kushal Naha is located at: University of Missouri - Ellis Fischel, Columbia, Missouri 65212 United States. This is the address for their practice at the University of Missouri - Ellis Fischel.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.